Literature DB >> 3158670

Circulating T-cell subsets in Guillain-Barré syndrome.

R P Lisak, B Zweiman, F Guerrero, A R Moskovitz.   

Abstract

We compared the distribution of circulating T-cell subsets within 2 weeks of onset of symptoms in 14 patients with acute Guillain-Barré syndrome (GBS) and 37 normal controls. The levels of OKT4+ (putative helper-inducer) cells was definitely abnormal (decreased) in 3/13 tested. The levels of OKT8+ (putative suppressor-cytotoxic) cells were elevated in 3 and decreased in 2 of the 14 tested. Abnormal OKT4/OKT8 ratios were detected in 5 (2 elevated and 3 decreased) patients. Four of the 5 GBS patients with abnormal OKT4+/OKT8+ ratios were studied sequentially at least 4 times over 1-10 months; there was a return towards a normal ratio in all. Serial studies in 3 other GBS patients showed consistently normal values. In comparison, sequential studies over 5-24 months in 7 normals showed no abnormal OKT4+/OKT8+ ratios. Thus, abnormalities in OKT4+/OKT8+ ratios appear to be a marker of systemic events during symptomatic phases of GBS. It is not as yet known whether this is related to the cause or is secondary to the clinical manifestations of GBS.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3158670     DOI: 10.1016/s0165-5728(85)80050-3

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  3 in total

Review 1.  Guillain-Barré syndrome after varicella-zoster infection. Report of two cases.

Authors:  E A Sanders; A C Peters; J W Gratana; R A Hughes
Journal:  J Neurol       Date:  1987-08       Impact factor: 4.849

Review 2.  Guillain-Barré syndrome: clinical and immunological aspects.

Authors:  A M Rostami
Journal:  Springer Semin Immunopathol       Date:  1995

3.  Changes in lymphocyte subsets in patients with Guillain-Barré syndrome treated with immunoglobulin.

Authors:  Hui Qing Hou; Jun Miao; Xue Dan Feng; Mei Han; Xiu Juan Song; Li Guo
Journal:  BMC Neurol       Date:  2014-10-15       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.